Fresenius Medical Care Ag · XETR:FME
Fresenius Medical Care — Corporate Update (December 2018)
6 slides from Fresenius Medical Care's corporate update, Dec 7, 2018
Slide 1: Fresenius Medical Care Conference Call
Fresenius Medical Care Rice Powell - CEO Michael Brosnan - CFO Conference Call December 07, 2018 © │ Conference Call│ December 2018 1
Slide 2: Safe harbor statement
Safe harbor statement: This presentation includes certain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Act of 1934, as amended. Forward- looking statements are inherently subject to risks and uncer
Slide 3: Key messages
Key messages Early preliminary indicative guidance for 2019: – Solid top line growth on a comparable basis – Net income on a comparable basis stable around the level of 2018 Business in 2019 driven by: – Build out of home dialysis services infrastructure as well as NxStage integration – Addition
Slide 4: Basis for revenue growth 2019
Basis for revenue growth 2019 Revenue (€m) 2018 target: 2-3% cc 17,784 559 335- 17,074- 703- 503 17,242 671 486 16,371- 16,739 16,571 15,850- 521 16,050 2017 Sound IFRS 15 2017 on a Business 2018 cc FX 2018 Sound 2018 reported H2 2017 comparable growth cc on a current on a H1 2018 comparable basis c
Slide 5: Basis for net income growth 2019
Basis for net income growth 2019 Net income (€m) 2018 target: 11-12% cc 137- 1,379 - 149 1,391 33-30 1,346 - 1,350 - 1,361 1,365 4 1,280 38 1,242 2017 Sound 2017 on a Business 2018 cc FX 2018 Sound 2018 reported H2 2017 comparable growth cc on a current on a H1 2018 comparable basis comparable compa
Slide 6: Your questions are welcome!
Fresenius Medical Care Rice Powell - CEO Michael Brosnan - CFO Your questions are welcome! Conference Call December 07, 2018 © │ Conference Call│ December 2018 6
Fresenius Medical Care — Corporate Update (December 2018) on 6ix